At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
ASBP Aspire Biopharma Holdings Inc.
Market Closed 01-16 16:00:00 EST
2.21
+0.13
+6.45%
盘后2.19
-0.02-0.90%
19:59 EST
High2.24Low1.65Vol1.20M
Open1.96D1 Closing2.08Amplitude28.19%
Mkt Cap7.65MTradable Cap6.80MTotal Shares3.46M
T/O2.34MT/O Rate38.93%Tradable Shares3.08M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Aspire Biopharma Holdings Inc trading halted, news pending
TIPRANKS  ·  01-16 08:50
Aspire Biopharma Holdings Inc trading halted, news pending
Aspire Biopharma Announces 1-for-40 Reverse Stock Split
Reuters  ·  01-14
Aspire Biopharma Announces 1-for-40 Reverse Stock Split
Aspire Biopharma Director Surendra Ajjarapu Resigns
Reuters  ·  01-14
Aspire Biopharma Director Surendra Ajjarapu Resigns
Aspire Biopharma Advances High-Dose Sublingual Aspirin to FDA-Supported Clinical Trial
Reuters  ·  01-07
Aspire Biopharma Advances High-Dose Sublingual Aspirin to FDA-Supported Clinical Trial
Aspire Biopharma Swaps $1.75 Million Debt for Common Stock
Reuters  ·  01-06
Aspire Biopharma Swaps $1.75 Million Debt for Common Stock
Aspire Biopharma Transfers Listing to Nasdaq Capital Market After Extension Granted
Reuters  ·  2025-12-13
Aspire Biopharma Transfers Listing to Nasdaq Capital Market After Extension Granted
Aspire Biopharma Reports Q3 2025 Update and Advances Sublingual Drug Delivery Programs
Reuters  ·  2025-12-04
Aspire Biopharma Reports Q3 2025 Update and Advances Sublingual Drug Delivery Programs
BRIEF-Aspire Biopharma Holdings Files For Offering Of Up To 41.5 Million Shares By Selling Shareholder - SEC Filing
Reuters  ·  2025-12-03
BRIEF-Aspire Biopharma Holdings Files For Offering Of Up To 41.5 Million Shares By Selling Shareholder - SEC Filing
Aspire Biopharma Holdings Inc Files for Offering of up to 41.5 Mln Shares by Selling Shareholder - SEC Filing
THOMSON REUTERS  ·  2025-12-03
Aspire Biopharma Holdings Inc Files for Offering of up to 41.5 Mln Shares by Selling Shareholder - SEC Filing
Aspire Biopharma Submits Pre-IND Meeting Request to FDA for Sublingual Aspirin Product
Reuters  ·  2025-12-02
Aspire Biopharma Submits Pre-IND Meeting Request to FDA for Sublingual Aspirin Product
Aspire Biopharma Holdings Adds Dr. Mark J. Jaroszeski to Scientific Team
Reuters  ·  2025-11-26
Aspire Biopharma Holdings Adds Dr. Mark J. Jaroszeski to Scientific Team
Aspire Biopharma Holdings Inc. Files Amendment to 10-Q Quarterly Report
Reuters  ·  2025-11-15
Aspire Biopharma Holdings Inc. Files Amendment to 10-Q Quarterly Report
Aspire Biopharma Hldgs Q3 EPS $(0.04) Down From $(0.01) YoY, Sales $1.941K
Benzinga  ·  2025-11-14
Aspire Biopharma Hldgs Q3 EPS $(0.04) Down From $(0.01) YoY, Sales $1.941K
Aspire Biopharma Holdings Inc - on Nov 11, Entered Eloc Agreement With Arena Business Solutions - SEC Filing
THOMSON REUTERS  ·  2025-11-14
Aspire Biopharma Holdings Inc - on Nov 11, Entered Eloc Agreement With Arena Business Solutions - SEC Filing
Aspire Biopharma Holdings - Under Eloc Agreement, Co Has Right but Not Obligation to Direct Arena to Purchase up to $100 Mln of Co’s Stock
THOMSON REUTERS  ·  2025-11-14
Aspire Biopharma Holdings - Under Eloc Agreement, Co Has Right but Not Obligation to Direct Arena to Purchase up to $100 Mln of Co’s Stock
Aspire Biopharma Announces $100 Million Unregistered Share Sale Under Equity Line Agreement
Reuters  ·  2025-11-14
Aspire Biopharma Announces $100 Million Unregistered Share Sale Under Equity Line Agreement
Aspire Biopharma Holdings Inc. held special shareholder meeting
Reuters  ·  2025-11-06
Aspire Biopharma Holdings Inc. held special shareholder meeting
Aspire Biopharma Faces Nasdaq Delisting After Compliance Failures
Reuters  ·  2025-10-18
Aspire Biopharma Faces Nasdaq Delisting After Compliance Failures
Aspire Biopharma Holdings Announces Breakthrough in Sublingual Drug Delivery with New Patent Application
Reuters  ·  2025-10-06
Aspire Biopharma Holdings Announces Breakthrough in Sublingual Drug Delivery with New Patent Application
Aspire Biopharma Holdings Inc. to Present Pipeline Updates at Noble Capital Markets Emerging Growth Virtual Equity Conference
Reuters  ·  2025-10-03
Aspire Biopharma Holdings Inc. to Present Pipeline Updates at Noble Capital Markets Emerging Growth Virtual Equity Conference

Introduction

Company Name.
Aspire Biopharma Holdings Inc.
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
PowerUp Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to focus on video gaming, gaming adjacent, and metaverse businesses. PowerUp Acquisition Corp. was incorporated in 2021 and is based in New York, New York.
Issue price:
--